
Tuesday, May 30, 2023 3:06:52 PM
You stick with your opinion that CRL the go-to manufacturer for nonrevenue biotech with 21,400 employees 150 locations and $4 billion in revue is a loser and therefore its better to start your own CDMO from scratch, fine with me.
According to you, all biotech managers dont understand how to build a biotech except the brilliant LP. Heck, you have to justify something for the dilution that shareholders have been through in order to pay for Linda's private CDMO.
Liked By
Spread the love. Be the first to like this post!
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
- Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands • InvestorsHub NewsWire • 03/13/2023 11:35:55 AM
- Northwest Bio Accuses Market Makers of Share Price Manipulation • TipRanks • 12/01/2022 03:29:04 PM
- Acquisition Completed: Endexx (EDXC)'s HYLA Secures 200k+ Unit Order; 4,500 Puffs per Unit • InvestorsHub NewsWire • 09/27/2022 01:33:31 PM
Green Egg to launch $150 million bond offer for quicklime products production kiln plant Sep 22, 2023 12:11 PM
Nate's Food Co. Announces Reverse Merger and Change of Control with JP Energy Group to Drive Global Expansion • NHMD • Sep 22, 2023 9:00 AM
Trio Petroleum Corp Provides Update on Testing of the HV-1 Discovery Well • TPET • Sep 21, 2023 9:38 AM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM